Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ALC.AX
HoldAlcidion Group Limited · Healthcare · Australia · $93M · Avg Vol: $102K/d
COMPANY DESCRIPTION
Alcidion Group Limited develops and licenses healthcare software solutions, including its flagship Miya Precision platform, which provides real-time clinical decision support and patient flow management. The company benefits from high customer switching costs and deep integration within public healthcare systems, particularly in the United Kingdom and Australia. It is a high-growth health informatics specialist with a highly scalable, software-as-a-service business model.
FINANCIAL SUMMARY (AUD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.9M | 34.4M | 40.4M | 37.1M | — | 12.7% | 51.8M | 54.7M | 59.6M | 12.6% |
| EPS (AUD) | -0.00 | -0.00 | -0.00 | -0.01 | 0.00 | — | — | 0.00 | 0.00 | 16.0% |
| Shares | — | 1.3B | 1.3B | 1.3B | — | +5.9% | 1.3B | — | — | — |
| Debt | — | 2.5M | 2.2M | 1.7M | — | -17.4% | 0.8M | — | — | — |
| Equity | — | 94.0M | 90.2M | 86.9M | — | -3.8% | — | — | — | — |
| Op CF | — | 1.0M | 0.2M | -7.1M | — | -83.0% | 6.9M | — | — | — |
| Inv CF | — | -59.7M | -3.1M | -53.0K | — | — | — | — | — | — |
| Fin CF | — | 51.3M | -0.6M | 4.3M | — | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ALC.AX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ALC.AX | Alcidion Group Limited(you) | $93M | 54 | Hold |
| BB1.AX | BlinkLab Limited | $86M | 21 | Sell |
| PHX.AX | PharmX Technologies Limited | $59M | 22 | Sell |
| PKY.AX | Pathkey.AI Ltd | $57M | 21 | Sell |
| AYA.AX | Artrya Limited | $557M | 35 | Hold |
| CGS.AX | Cogstate Limited | $380M | 92 | Strong Buy |
| EIQ.AX | Echo IQ Limited | $740M | 28 | Sell |
| ATHE | Alterity Therapeutics Limited | $82M | 54 | Hold |
| PGC.AX | Paragon Care Limited | $163M | 57 | Hold |
| MVF.AX | Monash IVF Group Limited | $190M | 56 | Hold |
Peer medians: ROE -25.5% · P/E 34.6x · Gross margin 61.1%